Type of Cancer
Gynecologic
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.